Natalia N. Kudryavtseva | Neurobiology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Natalia N. Kudryavtseva | Neurobiology | Best Researcher Award

Institute of Cytology and Genetics of SB RAS | Russia

Professor Natalia N. Kudryavtseva is a highly distinguished neuroscientist and leading researcher at the I.P. Pavlov Institute of Physiology RAS in Saint Petersburg and the Institute of Cytology and Genetics SB RAS in Novosibirsk, with extensive academic and research contributions in behavioral pharmacology, neurogenetics, and biological psychiatry. She completed her education at Novosibirsk State University in physiology and advanced to hold key positions as junior, senior, and leading researcher, later becoming head of the Neurogenetics of Social Behaviour Sector and the Neuropathology Modelling Laboratory. Her professional journey includes visiting research at Cold Spring Harbor Laboratory in the United States, along with teaching as professor of physiology at Novosibirsk State University. Her research interests span behavioral genetics, social biology, psychopharmacology, transcriptomic analysis, and modelling of psychoemotional disorders, particularly through the sensory contact model she developed, widely applied in the study of chronic social conflict and neuropsychiatric mechanisms. She is skilled in neurogenomics, experimental neurobiology, and psychopharmacological correction, with more than one hundred eighty publications and several books. She is an active member of international research societies and has collaborated with institutions across Europe and the USA. Recognized for her pioneering contributions, with a citation index exceeding four thousand and an h-index of thirty-seven, she has received numerous honors for advancing knowledge on the neurobiology of aggression and psychoemotional disorders, making her a truly deserving candidate for international recognition.

Profile: ORCID

Featured Publications

Jing Zhang | Medicinal Chemistry | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Jing Zhang | Medicinal Chemistry | Best Researcher Award

School of Life Sciences and Engineering | China

Dr. Jing Zhang, currently a lecturer at the School of Life Sciences and Engineering, Lanzhou University of Technology, is a dedicated scholar with a strong academic foundation built at Wuhan University, where she completed her bachelor’s and master’s studies in pharmaceutical sciences and medicinal chemistry and later earned a doctorate in pharmaceutical sciences. Her professional journey includes valuable research experience as a research intern at the Chinese Academy of Sciences in the Department of Magnetic Resonance Imaging, which enhanced her expertise in imaging technologies and drug delivery systems. Her research interests lie in the fields of nanomedicine, drug delivery, photodynamic and photothermal therapies, fluorine-based magnetic resonance imaging, and cancer therapeutics. She has contributed significantly to these domains through publications in high-impact journals such as Chemistry & Biodiversity, Advanced Healthcare Materials, The Journal of Organic Chemistry, and Chemical Communications, focusing on anticancer agents, traceable biomaterials, and estrogen receptor modulators. Dr. Zhang’s research skills span organic synthesis, polymer chemistry, molecular imaging, and the development of multifunctional nanocarriers for cancer treatment. Her achievements are further supported by prestigious research funding, including national and provincial projects and collaborations with pharmaceutical industries. Recognized for her diligence and truth-seeking approach, she continues to advance biomedical innovation with the potential to impact cancer diagnosis and therapy significantly, making her a promising leader in pharmaceutical sciences.

Profile: ORCID

Featured Publications

Yu-Young Lee | Natural Product-based Neuropharmacology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Yu-Young Lee | Natural Product-Based Neuropharmacology | Best Researcher Award

National Institute of Crop Science | South Korea

Dr. Yu-Young Lee is a distinguished scientist at the National Institute of Crop Science, Rural Development Administration, Korea, with a specialization in the chemistry of natural products and crop quality evaluation. Her career reflects a deep commitment to advancing agricultural sciences, particularly in improving the nutritional and functional value of food crops through innovative biochemical approaches. She has significantly contributed to research on soybeans, oats, wheat, rice, and peanuts, focusing on bioactive compounds and their roles in human health. With her extensive international collaborations, including research experiences at the USDA and Tufts University, she has established herself as a global leader in agricultural biochemistry and crop quality science. Her numerous publications in peer-reviewed journals showcase her expertise in natural product chemistry, food functionality, and crop science. Through her research, Dr. Lee continues to bridge the gap between agriculture and human nutrition, aiming to improve both food quality and global health.

Profile

Scopus

Education

Dr. Yu-Young Lee pursued her academic journey at Kyungpook National University, Daegu, Korea, where she completed her studies in agricultural biology and life sciences. She earned her Bachelor’s degree in Agricultural Biology, building a solid foundation in crop science and plant research. She then advanced her studies by completing a Master’s degree in Agriculture and Life Science, focusing her research on the isolation of oleanane triterpenes and trans-resveratrol from the root of peanuts, highlighting her early interest in natural products and bioactive compounds. Her academic path culminated in a Ph.D. in Agriculture and Life Science, where she concentrated on the development of tocochromanol compound-enhanced soybeans and the evaluation of their biological activities. This advanced work demonstrated her pioneering vision of integrating crop science with health-promoting biochemical innovations. Her educational background reflects her dedication to merging agricultural productivity with food science to enhance nutritional and functional values of crops.

Experience

Dr. Yu-Young Lee has built a distinguished career as a scientist at the National Institute of Crop Science, Rural Development Administration, Korea, where she has contributed extensively to crop quality research and evaluation. Her role encompasses investigating natural compounds in crops and developing methods to enhance their nutritional and functional properties. She has conducted international research as an invited scientist at the Human Nutrition Research Center on Aging at Tufts University and at the Soft Wheat Quality Laboratory at USDA-ARS, gaining global perspectives on agricultural and nutritional sciences. Her research extends across multiple crops, including soybeans, oats, wheat, rice, and peanuts, where she explores bioactive compounds and their potential benefits for human health. She has led and collaborated on numerous projects focusing on food quality, safety, and functionality, establishing herself as a trusted authority in agricultural biochemistry and crop research. Her professional journey reflects a balance of national service and global collaboration.

Awards and Honors

Dr. Yu-Young Lee’s outstanding contributions to agricultural science and natural product chemistry have earned her recognition within Korea and internationally. Her invited appointments as a visiting scientist at world-renowned institutions such as Tufts University and the USDA-ARS underscore her respected position in the global research community. She has received honors through research collaborations and publications in high-impact journals, reflecting her strong academic and scientific reputation. Her work on enhancing soybean, oat, and rice quality with bioactive compounds has been widely acknowledged for its originality and relevance to both food science and human health. She has been instrumental in developing innovative methodologies for analyzing crop quality, which has advanced national agricultural programs. By bridging crop science and nutrition, her work has supported food security initiatives while improving the value of staple crops. Her career stands as a testament to her dedication, excellence, and the impact of her scientific endeavors.

Research Focus

Dr. Lee’s research focuses on the chemistry of natural products and their application in improving crop quality and human health. She investigates bioactive compounds such as tocochromanols, avenanthramides, polyphenols, and triterpenes, aiming to enhance the nutritional and functional value of staple crops. Her studies span multiple crops, including soybeans, oats, rice, wheat, and peanuts, where she analyzes their biochemical properties, antioxidant potential, and biological effects. A key aspect of her work is developing functional foods through biochemical enrichment, such as tocochromanol-enhanced soybeans and germinated oat extracts with neuroprotective effects. She also explores food processing methods, post-harvest improvements, and crop germplasm evaluation to optimize both quality and safety. Her interdisciplinary approach integrates agricultural science, plant biochemistry, and nutritional research, making her contributions vital to global health and food security. By linking agricultural outputs with human well-being, she pioneers innovative strategies for functional crop development and sustainable food systems.

 

Publications

 

Title: Standardization of Germinated Oat Extracts and Their Neuroprotective Effects Against Aβ1-42 Induced Cytotoxicity in SH-SY5Y Cells
Year: 2025

Title: Oat Extract Avenanthramide-C Reverses Hippocampal Long-Term Potentiation Decline in Tg2576 Mice
Year: 2021

Title: Oat (Avena sativa) Extract against Oxidative Stress-Induced Apoptosis in Human Keratinocytes
Year: 2021

Title: Influences of hydrothermal and pressure treatments on compositional and hydration properties of wheat bran and dough mixing properties of whole wheat meal
Year: 2021

Title: Development of Nano Soy Milk through Sensory Attributes and Consumer Acceptability
Year: 2021

Title: Avenanthramide-C Restores Impaired Plasticity and Cognition in Alzheimer’s Disease Model Mice
Year: 2020

Title: Oat germination and ultrafiltration process improves the polyphenol and avenanthramide contents with protective effect in oxidative damaged HepG2 cells
Year: 2019

Title: Physicochemical and antioxidant properties of rice cooked with different proportions of black soybeans and cooking methods
Year: 2018

Title: Assessment of microbial safety and quality changes of brown and white cooked rice treated with atmospheric pressure plasma
Year: 2018

Title: Black soybeans protect human keratinocytes from oxidative stress-induced cell death
Year: 2018

Conclusion

Dr. Yu-Young Lee is a pioneering agricultural scientist whose expertise in natural product chemistry, crop quality enhancement, and functional food development continues to make a profound impact on global agriculture and human nutrition.

Sarah Leibowitz | Behavioral Neurobiology | Most Cited Article Award

Published on by Cognitive Scientist Awards

Dr. Sarah Leibowitz | Behavioral Neurobiology | Most Cited Article Award

The Rockefeller University | United States

Dr. Sarah F. Leibowitz is a Research Associate Professor at The Rockefeller University in the Laboratory of Behavioral Neurobiology. With a career dedicated to uncovering the neural basis of addiction, she focuses on how the brain regulates consumption of substances like alcohol and nicotine, as well as high-fat and high-sugar foods. Her pioneering work explores the transition from casual intake to substance dependence, linking specific brain mechanisms to addictive behaviors. Dr. Leibowitz’s research also highlights how emotional traits—such as impulsivity and anxiety—influence substance use. In recent years, she has expanded her work to investigate how maternal diet and drug exposure during pregnancy affect the brain development and behavior of offspring. Her studies reveal persistent neural and behavioral changes that may increase vulnerability to addiction later in life. Through her research, she aims to identify early indicators of addiction risk and explore preventive strategies for substance abuse disorders.

Profile

ORCID

Education

Dr. Sarah F. Leibowitz earned her Ph.D. in behavioral neurobiology, establishing her foundation in neuroscience and psychobiology. Although specific details of her academic institutions are not publicly disclosed, her academic trajectory clearly reflects rigorous training in neurobiology, endocrinology, and developmental neuroscience. Her education emphasized the interplay between brain structure, behavior, and environmental stimuli—especially as related to addiction and nutrition. Over the course of her doctoral and postdoctoral work, she developed specialized expertise in rodent models, neurochemical techniques, and behavioral neuroscience. Her educational background has equipped her to contribute significantly to the understanding of the neural mechanisms underlying addiction, impulsivity, and maternal influences on brain development. Dr. Leibowitz’s academic formation has not only shaped her robust research career but also positioned her as a mentor and thought leader in the intersection of behavioral neuroscience, addiction research, and developmental psychobiology.

 Experience

Dr. Sarah Leibowitz brings decades of experience in behavioral neuroscience, serving as a Research Associate Professor at The Rockefeller University. In this role, she leads research exploring how neurochemical circuits in the brain influence the consumption of addictive substances and palatable foods. Her experience spans experimental neurobiology, developmental studies, and translational addiction research, using advanced rodent models to simulate human behavioral patterns. She has worked extensively on characterizing the neural pathways that control emotional traits such as impulsivity and anxiety, which predispose individuals to addiction. In addition, Dr. Leibowitz has pioneered investigations into prenatal programming—studying how maternal substance use affects offspring neurodevelopment and behavior. Her career has been marked by interdisciplinary collaborations, significant grant support, and mentoring emerging scientists. Dr. Leibowitz’s extensive lab-based research experience has positioned her at the forefront of studies on addiction vulnerability, making meaningful contributions to both basic neuroscience and potential clinical applications.

Awards and Honors

While specific awards and honors for Dr. Sarah F. Leibowitz are not publicly detailed, her long-standing appointment at The Rockefeller University—a prestigious research institution—attests to her outstanding contributions in behavioral neurobiology. Recognition in the scientific community is reflected through her published research, influential collaborations, and leadership in addiction-related neuroscience. She is frequently cited in peer-reviewed journals, indicating strong academic impact and recognition from fellow researchers. Her studies addressing prenatal influences on addiction vulnerability have garnered widespread attention in developmental neuroscience and public health sectors. In addition to academic merit, Dr. Leibowitz’s role as a mentor and educator suggests acknowledgment of her commitment to training the next generation of scientists. The significance and longevity of her research position imply that she has received competitive research funding and peer-reviewed grants, further recognizing the value of her work in advancing understanding of substance use disorders.

Research Focus

Dr. Leibowitz’s research focuses on the neurobiological mechanisms underlying addiction, particularly the transition from use to dependence on substances like alcohol, nicotine, and palatable foods. Her laboratory investigates how neurochemical pathways in various brain regions drive compulsive consumption and are influenced by traits such as novelty seeking, impulsivity, and anxiety. A major area of her research explores the developmental origins of addiction: how maternal consumption of drugs or high-fat/high-sugar diets during pregnancy alters brain development and long-term behavior in offspring. These studies reveal that such prenatal exposures can “reprogram” the brain, increasing susceptibility to substance use disorders in adolescence and adulthood. Through rodent models, Dr. Leibowitz aims to identify biomarkers and early-life predictors of addiction risk, as well as investigate potential interventions for prevention. Her multidisciplinary approach integrates behavioral neuroscience, endocrinology, and developmental biology, contributing valuable insights into addiction’s origins, progression, and possible prevention strategies.

Publications

Title: Neurological Disorders Induced by Drug Use: Effects of Adolescent and Embryonic Drug Exposure on Behavioral Neurodevelopment
Year: 2024
Citations: 2

Title: Utility of the Zebrafish Model for Studying Neuronal and Behavioral Disturbances Induced by Embryonic Exposure to Alcohol, Nicotine, and Cannabis
Year: 2023
Citations: 8

Title: Role of Chemokine Cxcl12a in Mediating the Stimulatory Effects of Ethanol on Embryonic Development of Subpopulations of Hypocretin/Orexin Neurons and Their Projections
Year: 2023
Citations: 10

Title: Embryonic ethanol exposure induces ectopic Hcrt and MCH neurons outside hypothalamus in rats and zebrafish: Role in ethanol‐induced behavioural disturbances
Year: 2022
Citations: 18

Conclusion

Dr. Sarah F. Leibowitz’s work stands at the intersection of neuroscience, behavior, and developmental biology, providing groundbreaking insights into addiction, prenatal brain development, and preventive strategies for substance use disorders, making her a leading figure in behavioral neurobiology and addiction research.

 

Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Dr. Aila Gareayaghi is a committed psychiatrist based in Kocaeli, Türkiye, with a deep passion for trauma-focused therapy, online psychotherapy, and mood and anxiety disorders. She holds the position of Lecturer and Psychiatrist at Kocaeli University and serves as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye. Dr. Gareayaghi’s extensive clinical and academic work includes innovative research on telepsychiatry, particularly in post-disaster mental health following Türkiye’s 2023 Kahramanmaraş Earthquakes. Her international experience includes a clerkship at Johns Hopkins University, Maryland. Beyond her clinical practice, she is active in research, conference presentations, and has authored multiple peer-reviewed publications addressing PTSD, sexual dysfunction, and transphobia in healthcare. Dr. Gareayaghi is multilingual, speaks advanced English and elementary French, and is a passionate advocate for volunteerism, animal welfare, and nature conservation, integrating her holistic outlook into her psychiatric practice.

Profile

🎓 Education

Dr. Aila Gareayaghi began her academic journey with a High School Diploma from Matthew McNair Secondary School in Vancouver, Canada (2012). She earned her Doctor of Medicine (M.D.) from Bezmialem Vakıf University, Istanbul, Türkiye (2012-2018), where she built a strong foundation in medical sciences. During her medical training, she completed a prestigious clerkship in Gastroenterology at Johns Hopkins University, USA (2018), gaining international exposure to advanced clinical practices. Pursuing her passion for mental health, she specialized in Psychiatry at Kocaeli University, Türkiye (2020-2024). Under the mentorship of Prof. Dr. Elif Tatlıdil, she completed her thesis on “Telepsychiatry Services During the February 6 Earthquakes and PTSD Prevalence Six Months Later.” Additionally, Dr. Gareayaghi continuously expanded her expertise through numerous certifications in psychotherapy, cognitive behavioral therapy, dynamic psychotherapy, EMDR, and traditional Chinese medicine, emphasizing her dedication to comprehensive psychiatric care.

🧪 Experience

Dr. Gareayaghi’s professional experience reflects a blend of clinical practice, teaching, and research. She currently serves as Lecturer and Psychiatrist at the Department of Psychiatry, Kocaeli University (2024–Present), where she actively treats patients, mentors students, and conducts impactful research. As Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye, she plays a leadership role in advancing psychiatric practice and policy at the regional level. Her experience extends internationally, having completed a clinical clerkship in Gastroenterology at Johns Hopkins University, USA. Dr. Gareayaghi has presented her research extensively at national and international psychiatric congresses, covering topics from disaster psychiatry to psychosis and caregiver support. Her work demonstrates strong expertise in trauma therapy, online psychotherapy, and managing complex psychiatric conditions. She is also a prolific contributor to academic literature, authoring multiple peer-reviewed articles and book chapters addressing psychiatric emergencies and psychological trauma interventions.

🏅 Awards and Honors

Dr. Aila Gareayaghi has distinguished herself through numerous scientific contributions and recognitions. She has been invited as a speaker at prestigious forums such as the 59th National Psychiatry Congress and the Symposium on Disaster and Disaster Management. Her presentations on post-earthquake PTSD, antipsychotic-induced complications, and caregiver support have been recognized for their clinical relevance and academic rigor. Dr. Gareayaghi’s research, including peer-reviewed publications on telepsychiatry and transphobia in healthcare, reflects her innovative approach to contemporary psychiatric challenges. Although formal awards are not specified, her active involvement as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye and her multiple invited speaker roles demonstrate high professional regard and peer recognition. Moreover, her extensive certifications in psychotherapy modalities underscore her commitment to lifelong learning and excellence in patient care. Her dedication to volunteer work and animal welfare also highlight her compassionate engagement beyond academia.

🔬 Research Focus

Dr. Gareayaghi’s research focuses primarily on trauma-informed care, disaster psychiatry, and telepsychiatry, with a special emphasis on the mental health impact of natural disasters. Her thesis work examined the prevalence of PTSD following Türkiye’s 2023 earthquakes and the effectiveness of telepsychiatry services during disaster recovery. Additionally, her research explores societal and clinical aspects of sexual dysfunction, major depressive disorder, bipolar disorder, schizophrenia, and anxiety disorders. She has published studies addressing transphobia in healthcare, antipsychotic-induced complications, and innovative therapeutic interventions such as EMDR. Dr. Gareayaghi integrates various therapeutic modalities, including dynamic psychotherapy, cognitive behavioral therapy, and psychodynamic psychotherapy, into both her clinical practice and research. Her multidisciplinary approach bridges clinical psychiatry, public health, and social psychology, contributing valuable insights into the management of psychiatric emergencies and the psychological aftermath of crises. Her ongoing work continues to address evolving mental health challenges in both individual and systemic contexts.

✅ Conclusion

Dr. Aila Gareayaghi exemplifies a dynamic psychiatrist integrating clinical excellence, cutting-edge research, and compassionate care, with a focus on trauma therapy, disaster psychiatry, telepsychiatry, and comprehensive psychiatric education.

Publications

  • Ruh Sağlığında Kriz

    ÖGDA GAREAYAGHİ, UDH YILMAZ, A POLAT
    PSİKİYATRİK ACİLLER
  • A MEDICAL STUDENT’S PERSPECTIVE ON ANIMAL EXPERIMENTATION.
    A Gareayaghi
    The Turkish Journal of Gastroenterology: the Official Journal of Turkish …

  • Predictors of Transphobia and Attitudes Toward Transgender Individuals Among Nurses in Türkiye: A Cross-Sectional Study

    Healthcare
    2025-06-19 | Journal article
    DOI: 10.3390/healthcare13121474
    CONTRIBUTORS: Ezgi Şişman; Mehtap Güngör; Aila Gareayaghi; Hanife Yılmaz; Aslıhan Polat

  • Post-Earthquake PTSD and the Role of Telepsychiatry: A Six-Month Follow-Up Study After the 2023 Kahramanmaraş Earthquakes

    Medicina
    2025-06-17 | Journal article
    DOI: 10.3390/medicina61061097
    CONTRIBUTORS: Aila Gareayaghi; Elif Tatlıdil; Ezgi Şişman; Aslıhan Polat

  • Experiences with Brexpiprazole in the Management of Agitation Due to Dementia in a University Clinic: A Case Series

    Kocaeli Üniversitesi Sağlık Bilimleri Dergisi
    2025-03-21 | Journal article
    DOI: 10.30934/kusbed.1617807
    CONTRIBUTORS: Aila Gareayaghi; Ezgi Şişman; Mert Türksoy; Aslıhan Özlem Polat Işık

Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Dr. Dyandevi Mewalal Mathure, Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune, is a distinguished academician with over 15 years of experience in pharmaceutical sciences. Holding a Ph.D. in Pharmaceutical Sciences, she has significantly contributed to teaching, research, and innovation. Dr. Mathure has authored three notable books, published 18 research articles in reputed journals, and holds five published patents. Her research primarily focuses on nanoformulations for Alzheimer’s disease, wound healing, and topical formulations for skin diseases. She has successfully completed government-funded research projects and is actively engaged in industry consultancy work. Collaborating with institutions like the University of Petroleum and Energy Studies, Dehradun, Dr. Mathure continues to push the frontiers of pharmaceutical research. Her dedication is reflected in multiple accolades, including best paper presentation awards at international conferences. Committed to translational pharmaceutical advancements, she remains a passionate contributor to academia and industry alike.

Profile

🎓 Education

Dr. Dyandevi Mewalal Mathure earned her Ph.D. in Pharmaceutical Sciences, building a robust foundation in pharmaceutical research and innovation. Her academic journey has been characterized by a strong emphasis on novel drug delivery systems, formulation development, and translational research. She has engaged in continuous professional development, authoring several key texts in Industrial Pharmacy and Modern Dispensing Practices, which are widely used in academic curricula. Her educational background not only reflects depth in pharmaceutical sciences but also showcases her commitment to knowledge dissemination through teaching and publication. Her advanced training and research expertise in nanoformulations, brain-targeted drug delivery, and topical therapeutic systems underscore her position as a subject matter expert. Dr. Mathure’s education has enabled her to bridge theory and practice, equipping her with the skills to lead significant research projects, collaborate with industry partners, and mentor future pharmacists and researchers.

🧪 Experience

With over 15 years of academic and research experience, Dr. Dyandevi Mewalal Mathure has built a distinguished career as an Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune. Her professional journey encompasses extensive teaching, research supervision, and collaborative research projects. She has published 18 papers in esteemed SCI and Scopus-indexed journals, authored three textbooks, and successfully filed five patents. Dr. Mathure has completed one funded research project and is currently engaged in an ongoing industry consultancy project, demonstrating her ability to translate academic research into practical applications. Her collaborations with institutions like the University of Petroleum and Energy Studies highlight her commitment to multidisciplinary research. Additionally, her expertise in nanoformulations for Alzheimer’s disease, wound healing, and skin disorders reflects her diverse research interests. Through her dedicated mentorship and active participation in international conferences, she continues to inspire and guide students, contributing significantly to the advancement of pharmaceutical sciences.

🏅 Awards and Honors

Dr. Dyandevi Mewalal Mathure has been recognized for her outstanding research contributions through multiple awards and honors. Notably, she received the Best Paper Presentation Award at the international e-Conference on “Expanding Frontier of Pharmaceutical Research Towards Global Exigency,” organized by Karpagam College of Pharmacy in association with the Indian Pharmaceutical Association, Coimbatore Branch. Her consistent scholarly excellence is reflected in her extensive publication record and successful patent filings. Dr. Mathure’s innovative work has garnered appreciation from both academia and industry, enhancing her reputation as a leader in pharmaceutical research. In addition to her academic accolades, her active involvement in consultancy projects further validates the real-world impact of her research. Her sustained commitment to innovation, teaching excellence, and translational research has made her a strong contender for the Best Research Award, recognizing her as a role model in the field of pharmaceutical sciences.

🔬 Research Focus

Dr. Dyandevi Mewalal Mathure’s research focuses on developing advanced nanoformulations aimed at treating Alzheimer’s disease, promoting wound healing, and addressing various dermatological conditions through innovative topical formulations. Her work emphasizes the design and optimization of novel drug delivery systems that enhance therapeutic efficacy and patient compliance. Through her publications, patents, and consultancy projects, Dr. Mathure has contributed to the advancement of brain-targeted drug delivery, an area critical for managing neurodegenerative diseases. Her translational research bridges laboratory discoveries with clinical and industrial applications, offering practical solutions to complex medical challenges. Collaborations with reputed institutions like UPES Dehradun further demonstrate her commitment to multidisciplinary and applied pharmaceutical research. With a citation index of 6, she maintains an active presence in scientific discourse, continuously advancing the boundaries of pharmaceutical sciences. Her work exemplifies innovation-driven research with tangible societal impact.

✅ Conclusion

Dr. Dyandevi Mewalal Mathure’s distinguished academic career, marked by impactful research in nanoformulations, drug delivery, numerous publications, patents, and active industry collaborations, demonstrates her unwavering commitment to advancing pharmaceutical sciences and improving patient care through innovation and translational research.

Publications

Camille Blackman | Neurology and Gender-Affirming Care | Best Researcher Award

Published on by Cognitive Scientist Awards

Ms. Camille Blackman | Neurology and Gender-Affirming Care | Best Researcher Award

Camille Blackman is a dedicated medical student and multidisciplinary researcher with a passion for advancing gender-affirming healthcare and surgical education. Currently pursuing her MD at the University of Illinois College of Medicine, she brings a diverse background in anthropology, emergency medicine, and clinical research. Camille’s clinical experiences range from working as an EMT and physical therapist assistant to serving as a medical assistant in dermatology. Her current research at Johns Hopkins Center for Transgender and Gender Expansive Health centers on surgical outcomes, educational innovation, and health equity. She has published and presented nationally on topics like craniofacial surgery, sexual medicine, and transgender health. Outside of medicine, she is a nationally competitive runner and co-founder of Nameless Track Club. Camille also contributes to mentoring, leadership development, and medical education reform. Fluent in English and French, she exemplifies a well-rounded, compassionate, and forward-thinking physician in training.

Profile

🎓 Education

Camille Blackman’s academic journey reflects her interdisciplinary strength and commitment to health equity. She holds a Bachelor of Arts in Cultural Anthropology from Northwestern University (2012–2016), where she was also a Division 1 athlete. To transition into a medical career, she completed a post-baccalaureate pre-medical program at DePaul University (2016–2017). Camille is currently a Doctor of Medicine (MD) candidate at the University of Illinois College of Medicine, expected to graduate in 2026. Her medical education is enhanced by participation in the Surgical Exploration and Discovery (SEAD) program and leadership in multiple mentorship initiatives. Her academic excellence is evidenced by her involvement in high-impact research, her role as an M3 mentor, and her selection for honors like Academic All-Big Tens. Throughout her academic path, she has consistently demonstrated a commitment to inclusion, excellence in scholarship, and innovation in clinical care, especially for underserved populations such as the transgender and gender-diverse community.

🧪 Experience

Camille Blackman has built a robust portfolio of healthcare experience over nearly a decade. As a current research trainee at the Johns Hopkins Center for Transgender and Gender Expansive Health, she contributes to cutting-edge projects focused on surgical outcomes and health equity. Prior to that, she worked as a medical assistant at the Illinois Dermatology Institute (2020–2023), a physical therapist assistant at RUSH Rehabilitation (2018–2021), and an EMT at Medical Express Ambulance (2018–2020). Her roles have spanned both emergency and outpatient care, giving her a comprehensive clinical foundation. In addition to her hands-on experience, she’s actively involved in medical education as a mentor and peer leader at UICOM. Camille also volunteers in both clinical and community settings, including Face the Future Foundation and Ann & Robert H. Lurie Children’s Hospital. Her practical and research experience across diverse settings reinforces her trajectory as a future physician-leader in gender-affirming and reconstructive surgery.

🏅 Awards and Honors

Camille Blackman has been recognized for both academic and athletic excellence. She is a recipient of the prestigious Academic All-Big Ten award (2013–2016) and earned the John and Rita Canning and Dinn Brothers Student-Athlete Scholarships while at Northwestern University. In athletics, she is a Tracksmith-sponsored elite runner and has posted competitive times in major races, including a 2:48 marathon and top finishes in the Chicago 13.1 and Shamrock Shuffle. Her early accolades include the Western Massachusetts Athlete of the Year and the Tommy Cochary High School Mile Grant. As a medical student, she was selected for the Surgical Exploration and Discovery (SEAD) program and received a $25,000 pilot grant from the Hopkins Business of Health Initiative as a co-investigator for transgender health systems innovation. Her honors reflect a rare combination of scientific acumen, athletic discipline, and community impact, affirming her multifaceted contributions to medicine and public health.

🔬 Research Focus

Camille Blackman’s research centers on gender-affirming care, surgical education, and health disparities. At the Johns Hopkins Center for Transgender and Gender Expansive Health, she explores clinical outcomes related to chest masculinization and hormone therapy, and contributes to the development of transgender health infrastructure. She has authored and co-authored multiple peer-reviewed publications on subjects such as craniofacial surgery techniques, body mass index implications in gender-affirming surgeries, and innovative educational approaches like clay modeling in anatomy instruction. Camille’s forthcoming book chapters on vaginoplasty and transgender care centers further establish her as an emerging scholar in surgical education and gender health equity. She has presented her work at high-profile conferences, including the Plastic Surgery Research Council and the Sexual Medicine Society of North America. Through her research, Camille aims to enhance inclusivity, clinical outcomes, and the surgical learning experience, particularly in areas where historically marginalized populations have faced significant healthcare gaps.

✅ Conclusion

Camille Blackman is a future physician and trailblazer in gender-affirming healthcare whose interdisciplinary expertise, clinical compassion, and research innovation are advancing inclusive medicine, educational reform, and equity in surgical outcomes.

Publications

Forshing Lui | Neurology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Forshing Lui | Neurology | Best Researcher Award

Dr. For-Shing Lui, a U.S. citizen and licensed neurologist in California, the UK, and Hong Kong, is an esteemed academic and clinician with over four decades of international experience in neurology and internal medicine, currently serving as Professor of Neurology at California Northstate University College of Medicine (CNUCOM), where he contributes significantly to medical education, curriculum development, and professional regulatory boards.

Profile

Education 🎓

Dr. Lui completed his M.B.B.S. from the University of Hong Kong in 1978, followed by an internal medicine residency (1978–1982) at the same institution; he then undertook neurology fellowship training at Newcastle General Hospital, UK (1982–1984), and a neurology residency at UC Davis (1995–1999), also serving as Chief Resident; his qualifications include being a Diplomate of the American Board of Psychiatry and Neurology, Fellow of the Royal College of Physicians (Edinburgh), Fellow of the Hong Kong Academy of Medicine, and Fellow of the American Academy of Neurology.

Experience 👨‍🏫

Dr. Lui has served as Expert Consultant and Reviewer for the Medical Board of California, Professor and Course Director at CNUCOM since 2014, Chair of Clinical Sciences, and Vice Chair of Education; formerly, he was Staff Neurologist and Chief of Neurology at Kaiser Permanente, Clinical Professor at UC Davis, and practiced as a neurologist and internist in Hong Kong; his roles spanned clinical practice, academic leadership, curriculum design, quality assurance, and international consultancy.

Awards & Recognitions 🏅

Dr. Lui received the 2022 A.B. Baker Teacher Recognition Award from the American Academy of Neurology, the ITLE University Distinguished Teacher Award in 2021, and multiple CNUCOM Professor of the Year Awards (2019–2023); his national recognitions include listings in America’s Top Physicians and Sacramento Magazine’s Top Doctors; he won the Croucher Fellowship (1982), John Anderson Gold Medal (1978), and several medical school scholarships for academic excellence, including the Li Shu Fan Prize in Pharmacology.

Research Interests 🔬

Dr. Lui’s academic and clinical interests lie in neurology education, vascular neurology, neuroimaging, and multiple sclerosis, with a deep commitment to medical pedagogy and curriculum leadership; his research integrates neurodiagnostic techniques with clinical neurology, particularly in imaging-based teaching, and he has presented regularly at neuroradiology conferences and contributed to educational innovation in neurology training at both Kaiser Permanente and CNUCOM, reflecting a lifelong dedication to mentoring, patient care, and advancing neurologic knowledge.

Publications

Lucas Muñoz-Lopez | Neuroscience | Best Academic Researcher Award

Published on by Cognitive Scientist Awards

Dr. Lucas Muñoz-Lopez | Neuroscience | Best Academic Researcher Award

El Dr. Lucas Muñoz-López 🎓 es logopeda neurológico especializado en rehabilitación logopédica en daño neurológico 🧠, con amplia experiencia clínica y académica 👨‍🏫. Tras graduarse en Logopedia por la Universidad de Granada en 2015, combinó práctica profesional y formación de posgrado, incluyendo dos másteres y un doctorado con mención Cum Laude 🏅. Ha ejercido como docente universitario en Melilla y Ceuta, y colabora en investigación con publicaciones en revistas como Frontiers in Psychology 📖. Además, ha tutorizado numerosos TFG y TFM 🎓. Su trabajo integra logopedia clínica, investigación sobre alteraciones de la comunicación y neurociencias, aportando al avance académico y a la rehabilitación de pacientes. Es autor de un libro publicado y miembro activo en proyectos de evaluación y tratamiento en contextos educativos y sanitarios 🏥. Su pasión por la docencia y la terapia lo posiciona como referente en logopedia clínica e investigación 📈.

Profile

Education 🎓

Dr. Muñoz-López 🧠 inició su carrera académica con el Grado en Logopedia (2015) en la Universidad de Granada 🎓, complementándolo ese mismo año con un Máster en Logopedia Clínica en Daño Cerebral (Isep Clinic, Madrid) 💡. En 2017 completó su segundo máster en Neurociencias Básicas y Aplicadas y Dolor en la Facultad de Medicina de Granada 🔬. Culminó su formación con un Doctorado en Psicología y Logopedia en la Universidad de Granada (2021) con mención Cum Laude 🏅, convirtiéndose en experto en alteraciones de la comunicación y rehabilitación neurológica 🧬. Su formación académica combina sólidos conocimientos clínicos, teóricos y metodológicos para abordar con éxito la intervención logopédica y la investigación científica 🏛️. Además, su trabajo refleja una constante actualización y compromiso con la excelencia educativa y terapéutica 💯.

Experience 👨‍🏫

Desde 2015, el Dr. Muñoz-López 🩺 ha desarrollado una sólida trayectoria profesional como logopeda clínico, combinando práctica asistencial con docencia universitaria 👨‍🏫. Ha ejercido en el Centro de Valoración y Orientación de Granada como Auxiliar Técnico en Logopedia 🏥, además de impartir clases en los campus de Ceuta y Melilla de la Universidad de Granada 📚. Ha sido tutor de TFG y TFM en varias universidades, incluyendo la Universidad de Granada y la Universidad Internacional de La Rioja ✍️. Su experiencia docente abarca asignaturas de logopedia, neuropsicología y psicopedagogía en grados y másteres universitarios 🎓. Además, colabora activamente en proyectos de intervención educativa, rehabilitación y formación de futuros profesionales. Su enfoque multidisciplinar y experiencia en contextos clínicos y penitenciarios 🏛️ le permiten aplicar soluciones eficaces e innovadoras en su área.

Awards & Recognitions 🏅

Dr. Muñoz-López ha recibido mención Cum Laude 🎖️ por su tesis doctoral en Psicología y Logopedia en la Universidad de Granada (2021) 🏅. Su tesis fue publicada como libro 📗, reafirmando su valor académico. Ha logrado publicar en la revista Frontiers in Psychology (Q2, JCR 2.99) 🧠, destacándose en el área de psicología y neurociencias. También ha publicado en la revista Journal for Educators, Teachers and Trainers, indexada en bases relevantes como Scopus y Dialnet 📖. Su libro fue editado por la Editorial Académica Española, con índice ICEE de 0.299 📘. Estos reconocimientos consolidan su reputación científica, reflejando la calidad y relevancia de su producción académica, así como su compromiso con la excelencia investigadora y docente 🧑‍🔬✨.

Research Interests 🔬

El Dr. Muñoz-López centra su investigación en la rehabilitación logopédica de alteraciones de la comunicación 🗣️, disfagia 🥄 y terapia miofuncional 💪, con especial atención a contextos neurológicos y penitenciarios 🏛️. Su trabajo profundiza en la intersección entre neurociencias, psicología y logopedia 🧠, explorando tanto enfoques clínicos como educativos. Ha contribuido al avance del conocimiento en alteraciones del lenguaje, evaluación cognitiva y técnicas de intervención para pacientes con daño cerebral adquirido 🧬. Además, participa en estudios sobre integración social, intervención educativa en contextos de riesgo y psicología forense ⚖️. Su enfoque combina metodología cuantitativa, intervención basada en evidencia y aplicación clínica, orientado siempre a mejorar la calidad de vida de las personas con trastornos de la comunicación 💬💡.

Publications

  • Validation and Spanish Adaptation of the Resilience Scale ER-23 in a University Population

    Healthcare
    2025-04-12 | Journal article
    DOI: 10.3390/healthcare13080886
    CONTRIBUTORS: Isabel Ramírez-Uclés; Julia Otero; F. Pablo Holgado-Tello; Lucas Muñoz-López; María B. Sánchez-Barrer

  • Analysis of writing in personality disorders in prison population

    Frontiers in Psychiatry
    2024 | Journal article
    DOI: 10.3389/fpsyt.2024.1391463
    EID:
    Part ofISSN: 16640640
    CONTRIBUTORS: Muñoz-López, L.; Fernández-García-Valdecasas, B.; López-Rodríguez, S.; Sánchez-Barrera, M.B.

  • Transformation of Higher Education: Discussion of the Dimensions, Trends and Scenarios of Change in Ibero-America

    Education Sciences
    2024 | Journal article
    DOI: 10.3390/educsci14050523
    Part ofISSN: 22277102
    CONTRIBUTORS: Fernández Cruz, M.; Fernández García Valdecasas, B.; Muñoz López, L.; López Rodríguez, S

  • Associations of Reversal Learning Performance With Personality Disorder Profile and Drug Abuse History in a Sample of Prison Inmates

    2024-09-18 | Journal article
    DOI: 10.1177/10731911241278307
    CONTRIBUTORS: Raquel Martín-Ríos; José C. Perales; Francisca López-Torrecillas; Lucas Muñoz Lóp

Jolanta Dorszewska | Neurobiology | Women Researcher Award

Published on by Cognitive Scientist Awards

Dr. Jolanta Dorszewska | Neurobiology | Women Researcher Award

Professor Jolanta Dorszewska is a globally recognized neuroscientist and pharmacologist based at Poznan University of Medical Sciences, Poland 🧠🇵🇱. She leads the Laboratory of Neurobiology, exploring the molecular and genetic basis of neurodegenerative diseases 🧬. With over 35 years of academic experience, her work spans neurochemistry, clinical neurology, and genetic research in Alzheimer’s and Parkinson’s disease 🧪. A prolific author, she has contributed to 80+ research papers, 50+ reviews, and 30+ book chapters 📚. She serves on editorial boards of top neuroscience journals and holds leadership roles in national and international neurological societies 🌍.

Profile

Education 🎓

Prof. Dorszewska earned her M.Sc. in Pharmacy with distinction from Poznan University of Medical Sciences in 1987 🏅. She completed board certifications in Pharmaceutical Analytics (1990 & 1997) and received her Ph.D. in 1996 🧪. In 2004, she qualified as an Associate Professor and achieved full Professorship in 2016 🎓. Her academic growth includes training in medical genetics from 2012 to 2020 🧬. Her education reflects an evolving blend of pharmacy, neurobiology, and genetics, forming the foundation of her current research excellence 💡.

Experience 👨‍🏫

Prof. Dorszewska began as an Assistant in the Dept. of Pharmacy (1987-88), then in Clinical Neurochemistry (1988-96) at PUMS 👩‍🔬. She was a Research Scientist in New York (1999–2000) 🗽 and has led the Laboratory of Neurobiology since 2004 🧠. She became Full Professor in 2022 🏛️. She also lectured at the National High Medical School in Pila (2012–2018) 📖. Her career blends hands-on research, global collaboration, and dedicated academic leadership 📚. She continues to mentor, publish, and drive innovations in neurology and neurochemistry 🚀

Awards & Recognitions 🏅

Awards and Honors:
Prof. Dorszewska is a Local Honorary Member of the 12th World Congress on Controversies in Neurology (2018) 🌐. She has served as Guest Editor for 6 prestigious theme issues and holds editorial roles in top-tier journals like Frontiers in Molecular Neuroscience and Current Alzheimer Research 📘. A section and associate editor for journals across the USA, UK, and Poland 🌍, she’s a key figure in scientific publishing 🖋️. She’s affiliated with the Polish Academy of Sciences and international neurological societies and has co-edited 5 books 📚.

Research Interests 🔬

Research Focus:
Her research spans lipid metabolism in hypoxia 🧫, cerebral sterols 🧠, neurotransmitters (serotonin, dopamine) 🧪, apoptosis in aging and disease (Alzheimer’s, Parkinson’s) 💔, and gene polymorphisms (MTHFR, MAO-B, PARK) 🧬. She investigates homocysteine metabolism, catecholamine pathways, and molecular changes in neurodegeneration 🧠. Since 2009, she’s focused on genetic mutations (PARK, APOE), biomarkers (ASN, microRNAs), and migraine genetics ⚙️. She uses advanced techniques like HPLC, PCR, ELISA, and immunohistochemistry 🔍. Her interdisciplinary work integrates neurobiology, pharmacogenomics, and molecular neuroscience in tackling brain diseases 🚀.

Publications 

  • Genetic variants of ZNF746 and the level of plasma Parkin, PINK1, and ZNF746 proteins in patients with Parkinson’s disease

    IBRO Neuroscience Reports
    2025-06 | Journal article
    DOI: 10.1016/j.ibneur.2025.01.016
    CONTRIBUTORS: Jolanta Dorszewska; Jolanta Florczak-Wyspiańska; Bartosz Słowikowski; Wojciech Owecki; Oliwia Szymanowicz; Ulyana Goutor; Mateusz Dezor; Paweł P. Jagodziński; Wojciech Kozubski

  • Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis

    Sclerosis
    2025-04-03 | Journal article
    DOI: 10.3390/sclerosis3020013
    CONTRIBUTORS: Katarzyna Wiszniewska; Małgorzata Wilk; Małgorzata Wiszniewska; Joanna Poszwa; Oliwia Szymanowicz; Wojciech Kozubski; Jolanta Dorszewsk

  • Unraveling the Role of Proteinopathies in Parasitic Infections

    Biomedicines
    2025-03-03 | Journal article
    DOI: 10.3390/biomedicines13030610
    CONTRIBUTORS: Mikołaj Hurła; Damian Pikor; Natalia Banaszek-Hurła; Alicja Drelichowska; Jolanta Dorszewska; Wojciech Kozubski; Elżbieta Kacprzak; Małgorzata Paul

  • Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain—The Effects of Memantine

    International Journal of Molecular Sciences
    2025-02-14 | Journal article
    DOI: 10.3390/ijms26041634
    CONTRIBUTORS: Małgorzata Anna Lewandowska; Agata Różycka; Teresa Grzelak; Bartosz Kempisty; Paweł Piotr Jagodziński; Margarita Lianeri; Jolanta Dorszewska